• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于实验性诱导结肠炎大鼠模型结肠特异性药物递送的pH敏感纳米球。

pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.

作者信息

Makhlof Abdallah, Tozuka Yuichi, Takeuchi Hirofumi

机构信息

Department of Pharmaceutical Engineering, Gifu Pharmaceutical University, Gifu, Japan.

出版信息

Eur J Pharm Biopharm. 2009 May;72(1):1-8. doi: 10.1016/j.ejpb.2008.12.013.

DOI:10.1016/j.ejpb.2008.12.013
PMID:19348015
Abstract

Novel pH-sensitive nanospheres designed for colon-specific delivery were prepared using polymeric mixtures of poly (lactic-co-glycolic) acid (PLGA) and a pH-sensitive methacrylate copolymer. Budesonide (BSD), a topically active corticosteroid, was entrapped as a model drug. The therapeutic efficacy of the prepared nanospheres was assessed using the trinitrobenzenesulfonic acid (TNBS) colitis rat model, in comparison with conventional enteric microparticles. In addition, the colon targeting properties, systemic bioavailability, and specific uptake by the inflamed colon mucosa were evaluated using coumarin-6 (C-6)-loaded nanospheres. The prepared nanospheres showed strongly pH-dependent drug release properties in acidic and neutral pH values followed by a sustained release phase at pH 7.4. Animal experiments revealed the superior therapeutic efficiency of BSD-loaded nanospheres in alleviating the conditions of TNBS-induced colitis model. The in vivo studies using C-6-loaded nanospheres displayed higher colon levels and lower systemic availability of the fluorescent marker when compared with simple enteric coating. Moreover, quantitative analysis of the fluorescent marker and confocal laser scanning studies showed strong and specific adhesion of the nanospheres to the ulcerated and inflamed mucosal tissue of the rat colon. In conclusion, the proposed nanosphere system combined the properties of pH-sensitivity, controlled release, and particulate targeting that could be useful for colon-specific delivery in inflammatory bowel disease.

摘要

采用聚(乳酸 - 乙醇酸)共聚物(PLGA)和pH敏感型甲基丙烯酸酯共聚物的聚合物混合物制备了用于结肠特异性递送的新型pH敏感纳米球。将具有局部活性的皮质类固醇布地奈德(BSD)作为模型药物包封其中。与传统的肠溶微粒相比,使用三硝基苯磺酸(TNBS)结肠炎大鼠模型评估了所制备纳米球的治疗效果。此外,使用负载香豆素 - 6(C - 6)的纳米球评估了结肠靶向特性、全身生物利用度以及炎症结肠黏膜的特异性摄取。所制备的纳米球在酸性和中性pH值下表现出强烈的pH依赖性药物释放特性,随后在pH 7.4时进入缓释阶段。动物实验表明,负载BSD的纳米球在缓解TNBS诱导的结肠炎模型病情方面具有卓越的治疗效果。与简单的肠溶包衣相比,使用负载C - 6的纳米球进行的体内研究显示荧光标记物在结肠中的含量更高,全身利用率更低。此外,荧光标记物的定量分析和共聚焦激光扫描研究表明,纳米球与大鼠结肠溃疡和炎症黏膜组织具有强烈且特异性的粘附。总之,所提出的纳米球系统结合了pH敏感性、控释和颗粒靶向特性,可用于炎症性肠病的结肠特异性递送。

相似文献

1
pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.用于实验性诱导结肠炎大鼠模型结肠特异性药物递送的pH敏感纳米球。
Eur J Pharm Biopharm. 2009 May;72(1):1-8. doi: 10.1016/j.ejpb.2008.12.013.
2
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.载布地奈德的纳米粒,具有 pH 敏感性包衣,用于改善炎症性肠病小鼠模型中的黏膜靶向性。
J Control Release. 2014 Jun 10;183:167-77. doi: 10.1016/j.jconrel.2014.03.039. Epub 2014 Mar 29.
3
Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.使用双pH和时间依赖性聚合物纳米颗粒实现布地奈德的结肠靶向递送用于结肠炎治疗。
Drug Des Devel Ther. 2015 Jul 21;9:3789-99. doi: 10.2147/DDDT.S88672. eCollection 2015.
4
Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon.用于靶向药物递送至炎症结肠的酶/ pH双敏感聚合物纳米颗粒。
Colloids Surf B Biointerfaces. 2014 Nov 1;123:271-8. doi: 10.1016/j.colsurfb.2014.09.026. Epub 2014 Sep 20.
5
In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.使用实验性诱导结肠炎大鼠动物模型对5-氨基水杨酸结肠靶向片进行体内评价
AAPS PharmSciTech. 2015 Dec;16(6):1445-54. doi: 10.1208/s12249-015-0331-z. Epub 2015 May 28.
6
Optimization of budesonide compression-coated tablets for colonic delivery.用于结肠给药的布地奈德肠溶衣片的优化。
AAPS PharmSciTech. 2009;10(1):147-57. doi: 10.1208/s12249-009-9188-3. Epub 2009 Feb 6.
7
Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.LK-423 在结肠递药微囊中给药时治疗大鼠实验性结肠炎的疗效增强。
J Microencapsul. 2010;27(7):572-82. doi: 10.3109/02652048.2010.501393.
8
Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.壳聚糖修饰的聚(D,L-乳酸-共-乙醇酸)纳米球用于溃疡性结肠炎的口服核因子-κB 寡核苷酸递药系统。
Biomaterials. 2011 Jan;32(3):870-8. doi: 10.1016/j.biomaterials.2010.09.034.
9
N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.N-琥珀酰壳聚糖载 5-氨基水杨酸系统用于结肠给药:在大鼠三硝基苯磺酸诱导结肠炎模型中的体内研究。
Int J Pharm. 2011 Sep 15;416(1):145-54. doi: 10.1016/j.ijpharm.2011.06.025. Epub 2011 Jun 23.
10
Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.基于负载淫羊藿苷的海藻酸钠-壳聚糖微球的结肠靶向口服给药系统治疗溃疡性结肠炎
Int J Pharm. 2016 Dec 30;515(1-2):176-185. doi: 10.1016/j.ijpharm.2016.10.002. Epub 2016 Oct 3.

引用本文的文献

1
Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems.基于蛋白质的纳米颗粒药物递送系统在炎症性肠病口服治疗中的进展。
Drug Deliv. 2025 Dec;32(1):2544689. doi: 10.1080/10717544.2025.2544689. Epub 2025 Aug 11.
2
pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment.用于溃疡性结肠炎治疗的pH依赖性药物递送系统。
Pharmaceutics. 2025 Feb 10;17(2):226. doi: 10.3390/pharmaceutics17020226.
3
Ionically bridged dexamethasone sodium phosphate-zinc-PLGA nanocomplex in alginate microgel for the local treatment of ulcerative colitis.
离子桥接的地塞米松磷酸钠-锌-PLGA 纳米复合物在海藻酸钠微凝胶中用于溃疡性结肠炎的局部治疗。
Arch Pharm Res. 2023 Jul;46(7):646-658. doi: 10.1007/s12272-023-01456-z. Epub 2023 Aug 3.
4
Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives.响应型纳米系统在溃疡性结肠炎靶向治疗中的应用:现状与未来展望。
Drug Deliv. 2023 Dec;30(1):2219427. doi: 10.1080/10717544.2023.2219427.
5
Fabrication and optimization of itraconazole-loaded zein-based nanoparticles in coated capsules as a promising colon-targeting approach pursuing opportunistic fungal infections.载酮康唑的玉米醇溶蛋白纳米粒的制备及优化——一种有前途的靶向结肠的方法,用于治疗机会性真菌感染。
Drug Deliv Transl Res. 2023 Dec;13(12):2982-3002. doi: 10.1007/s13346-023-01365-0. Epub 2023 Jun 3.
6
pH-sustaining nanostructured hydroxyapatite/alginate composite hydrogel for gastric protection and intestinal release of GG.用于胃保护和姜黄素肠道释放的pH维持性纳米结构羟基磷灰石/海藻酸盐复合水凝胶
Bioeng Transl Med. 2023 Apr 19;8(3):e10527. doi: 10.1002/btm2.10527. eCollection 2023 May.
7
Assessing acute colitis induced by dextran sulfate sodium in rats and its impact on gastrointestinal fluids.评估葡聚糖硫酸钠诱导的大鼠急性结肠炎及其对胃肠液的影响。
Drug Deliv Transl Res. 2023 May;13(5):1484-1499. doi: 10.1007/s13346-023-01313-y. Epub 2023 Mar 13.
8
Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon.一种新型多颗粒剂型的制备与表征,该剂型载有布地奈德壳聚糖纳米颗粒以提高结肠中微丸的效率。
Pharmaceutics. 2022 Dec 26;15(1):69. doi: 10.3390/pharmaceutics15010069.
9
Formulation of pH-Responsive Methacrylate-Based Polyelectrolyte-Stabilized Nanoparticles for Applications in Drug Delivery.用于药物递送的基于甲基丙烯酸酯的pH响应性聚电解质稳定纳米颗粒的配方
ACS Appl Nano Mater. 2022 Dec 23;5(12):18770-18778. doi: 10.1021/acsanm.2c04539. Epub 2022 Nov 24.
10
Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages.透明质酸偶联聚乳酸-羟基乙酸共聚物纳米粒通过CD44介导的对炎症性结肠组织和巨噬细胞的双重靶向作用减轻溃疡性结肠炎
Pharmaceutics. 2022 Oct 5;14(10):2118. doi: 10.3390/pharmaceutics14102118.